| Dr Christopher Pascual Campana, OD | |
|
300 E Lake Mead Pkwy, Henderson, NV 89015-5576 | |
| (702) 435-4301 | |
| (702) 435-4302 |
| Full Name | Dr Christopher Pascual Campana |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 300 E Lake Mead Pkwy, Henderson, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154763662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 766 (Nevada) | Primary |
| 152W00000X | Optometrist | 14622 (California) | Secondary |
| Provider Name | Long Kevin Diep O D P C |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841542438 PECOS PAC ID: 5193974970 Enrollment ID: O20121011000599 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.
GE Healthcare today announced FDA clearance of Optima XR220amx, Optima XR200amx and Brivo XR285amx - a new platform of user-friendly, mobile x-ray systems offering improvements from its predecessors in reliability, accessibility and flexibility to help address the increasingly specialized radiographic needs of patients.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
› Verified 5 days ago
| Provider Name | Spring Mountain Vision, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932426251 PECOS PAC ID: 7214173707 Enrollment ID: O20130430000118 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.
GE Healthcare today announced FDA clearance of Optima XR220amx, Optima XR200amx and Brivo XR285amx - a new platform of user-friendly, mobile x-ray systems offering improvements from its predecessors in reliability, accessibility and flexibility to help address the increasingly specialized radiographic needs of patients.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
› Verified 5 days ago
| Provider Name | Ngo & Campana Od Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215302179 PECOS PAC ID: 5799080974 Enrollment ID: O20160225002010 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.
GE Healthcare today announced FDA clearance of Optima XR220amx, Optima XR200amx and Brivo XR285amx - a new platform of user-friendly, mobile x-ray systems offering improvements from its predecessors in reliability, accessibility and flexibility to help address the increasingly specialized radiographic needs of patients.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Pascual Campana, OD 300 E Lake Mead Pkwy, Henderson, NV 89015-5576 Ph: (702) 435-4301 | Dr Christopher Pascual Campana, OD 300 E Lake Mead Pkwy, Henderson, NV 89015-5576 Ph: (702) 435-4301 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.
GE Healthcare today announced FDA clearance of Optima XR220amx, Optima XR200amx and Brivo XR285amx - a new platform of user-friendly, mobile x-ray systems offering improvements from its predecessors in reliability, accessibility and flexibility to help address the increasingly specialized radiographic needs of patients.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
› Verified 5 days ago
Dr. Aaron Mancuso, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2461 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-636-2020 Fax: 702-616-2133 | |
Dr. Angela Khakshooy, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2703 Peekskill Ave, Henderson, NV 89052 Phone: 310-804-4468 | |
Nancy Tran Phan Gauthier, OD Optometrist Medicare: Medicare Enrolled Practice Location: 695 S Green Valley Pkwy, Henderson, NV 89052 Phone: 702-407-2455 | |
Braden Sorensen Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 680 S Green Valley Pkwy Ste 120, Henderson, NV 89052 Phone: 702-889-3937 | |
Kimberly Le Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 300 E Lake Mead Pkwy, Henderson, NV 89015 Phone: 858-348-7790 | |
Dr. Joseph Lao, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 543 N Stephanie St Ste 110, Henderson, NV 89014 Phone: 702-888-1079 Fax: 702-333-1016 | |
Trang Tam Tran, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 540 Marks St, Henderson, NV 89014 Phone: 702-434-2441 Fax: 702-434-6409 |